Protokinetix Inc (PKTX) financial statements (2021 and earlier)

Company profile

Business Address 412 MULBERRY STREET
MARIETTA, OH 45750
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1933771363033713710
Cash and cash equivalents1933771363033713710
Receivables     85
Prepaid expense11162700 
Total current assets:1943781373654413796
Noncurrent Assets
Intangible assets, net (including goodwill)27520818815310170 
Intangible assets, net (excluding goodwill)27520818815310170 
Total noncurrent assets:27520818815310170 
TOTAL ASSETS:4695863255185424506
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:272679274545271
Accrued liabilities      8
Other undisclosed accounts payable and accrued liabilities272679274545263
Debt   118  227
Other undisclosed current liabilities(9)      
Total current liabilities:1826791454545497
Noncurrent Liabilities
Long-term debt and lease obligation      84
Long-term debt, excluding current maturities      84
Other undisclosed noncurrent liabilities27      
Total noncurrent liabilities:27     84
Other undisclosed liabilities      (147)
Total liabilities:4526791454545434
Stockholders' equity
Stockholders' equity attributable to parent, including:424560246374497404(428)
Common stock2111111
Common stock, value, subscriptions      25
Additional paid in capital43,61536,10731,59530,50629,11627,49925,412
Accumulated deficit(43,193)(35,548)(31,350)(30,134)(28,620)(27,096)(25,841)
Other undisclosed stockholders' equity attributable to parent      (25)
Other undisclosed stockholders' equity0      
Total stockholders' equity:424560246374497404(428)
TOTAL LIABILITIES AND EQUITY:4695863255185424506

Income statement (P&L) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues
(Other Income)
      250
Cost of revenue
(Cost of Goods and Services Sold)
     (125)(95)
Gross profit:     (125)155
Operating expenses(7,644)(4,198)(1,216)(1,514)(1,525)(1,262)(419)
Operating loss:(7,644)(4,198)(1,216)(1,514)(1,525)(1,387)(264)
Interest and debt expense  (0)(2)(0)7161
Net loss:(7,644)(4,198)(1,217)(1,515)(1,525)(1,380)(103)
Other undisclosed net income (loss) attributable to parent  020125(66)
Net loss available to common stockholders, diluted:(7,644)(4,198)(1,216)(1,514)(1,525)(1,255)(168)

Comprehensive Income ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(7,644)(4,198)(1,217)(1,515)(1,525)(1,380)(103)
Comprehensive loss, net of tax, attributable to parent:(7,644)(4,198)(1,217)(1,515)(1,525)(1,380)(103)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: